ES2163634T3 - Benzopiranos y composiciones farmaceuticas que les contienen. - Google Patents

Benzopiranos y composiciones farmaceuticas que les contienen.

Info

Publication number
ES2163634T3
ES2163634T3 ES96917431T ES96917431T ES2163634T3 ES 2163634 T3 ES2163634 T3 ES 2163634T3 ES 96917431 T ES96917431 T ES 96917431T ES 96917431 T ES96917431 T ES 96917431T ES 2163634 T3 ES2163634 T3 ES 2163634T3
Authority
ES
Spain
Prior art keywords
benzopirans
contain
pharmaceutical compositions
rocesos
benzopiranos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96917431T
Other languages
English (en)
Spanish (es)
Inventor
Paul W Manley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2163634(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2163634T3 publication Critical patent/ES2163634T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES96917431T 1995-05-24 1996-05-24 Benzopiranos y composiciones farmaceuticas que les contienen. Expired - Lifetime ES2163634T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9510477.4A GB9510477D0 (en) 1995-05-24 1995-05-24 Organic compounds

Publications (1)

Publication Number Publication Date
ES2163634T3 true ES2163634T3 (es) 2002-02-01

Family

ID=10774940

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96917431T Expired - Lifetime ES2163634T3 (es) 1995-05-24 1996-05-24 Benzopiranos y composiciones farmaceuticas que les contienen.

Country Status (30)

Country Link
US (1) US5905156A (https=)
EP (1) EP0828733B1 (https=)
JP (1) JPH11505820A (https=)
KR (1) KR100437981B1 (https=)
CN (1) CN1077888C (https=)
AR (1) AR004489A1 (https=)
AT (1) ATE205204T1 (https=)
AU (1) AU703276B2 (https=)
BR (1) BR9609048A (https=)
CA (1) CA2217821C (https=)
CO (1) CO4700520A1 (https=)
CZ (1) CZ294474B6 (https=)
DE (1) DE69615019T2 (https=)
DK (1) DK0828733T3 (https=)
ES (1) ES2163634T3 (https=)
FI (1) FI973992A7 (https=)
GB (1) GB9510477D0 (https=)
HU (1) HU222772B1 (https=)
IL (1) IL118382A (https=)
MY (1) MY114924A (https=)
NO (1) NO314846B1 (https=)
NZ (1) NZ309765A (https=)
PL (1) PL184144B1 (https=)
PT (1) PT828733E (https=)
RU (1) RU2160735C2 (https=)
SK (1) SK283215B6 (https=)
TR (1) TR199701417T1 (https=)
TW (1) TW421646B (https=)
WO (1) WO1996037490A1 (https=)
ZA (1) ZA964209B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
GB9822024D0 (en) * 1998-10-09 1998-12-02 Novartis Ag Organic compounds
GB9909792D0 (en) * 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
US6384244B2 (en) 2000-05-18 2002-05-07 Merck & Co., Inc. Process for preparing cis- aminochromanols
KR101078357B1 (ko) * 2002-08-29 2011-10-31 닛산 가가쿠 고교 가부시키 가이샤 아미노벤조피란 화합물의 제조방법
US7098340B2 (en) 2003-05-14 2006-08-29 Warner Lambert Company Llc Benzyl sulfonamide derivatives
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체
CA2999769A1 (en) 2015-09-28 2017-04-06 Genentech, Inc. Therapeutic compounds and methods of use thereof
CN106008288A (zh) * 2016-06-15 2016-10-12 西北农林科技大学 一种苯磺酰胺类化合物及其用途
JP2020511511A (ja) * 2017-03-24 2020-04-16 ジェネンテック， インコーポレイテッド ナトリウムチャネル阻害剤としての４−ピペリジン−ｎ−（ピリミジン−４−イル）クロマン−７−スルホンアミド誘導体
TW202003490A (zh) 2018-05-22 2020-01-16 瑞士商赫孚孟拉羅股份公司 治療性化合物及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
ES2030627A6 (es) * 1990-11-28 1992-11-01 Uriach & Cia Sa J Procedimiento para la obtencion de compuestos benzopiranicos.
GB9102803D0 (en) * 1991-02-11 1991-03-27 Ici Plc Pyridine compounds
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
TW244350B (https=) * 1991-12-14 1995-04-01 Hoechst Ag
US5236935A (en) * 1992-05-21 1993-08-17 Korea Research Institute Of Chemical Technology Benzopyran derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
CN1185153A (zh) 1998-06-17
AR004489A1 (es) 1998-12-16
NZ309765A (en) 2000-01-28
DE69615019D1 (de) 2001-10-11
IL118382A (en) 2000-01-31
PL184144B1 (pl) 2002-09-30
CO4700520A1 (es) 1998-12-29
SK283215B6 (sk) 2003-03-04
CA2217821A1 (en) 1996-11-28
TW421646B (en) 2001-02-11
CZ368897A3 (cs) 1998-02-18
CZ294474B6 (cs) 2005-01-12
IL118382A0 (en) 1996-09-12
HUP9801751A2 (hu) 1999-06-28
NO314846B1 (no) 2003-06-02
KR19990021925A (ko) 1999-03-25
GB9510477D0 (en) 1995-07-19
NO975365D0 (no) 1997-11-21
TR199701417T1 (xx) 1998-02-21
HK1014137A1 (en) 1999-09-24
ATE205204T1 (de) 2001-09-15
DE69615019T2 (de) 2002-06-06
JPH11505820A (ja) 1999-05-25
MX9709004A (es) 1998-03-31
FI973992L (fi) 1997-12-09
SK157797A3 (en) 1998-05-06
EP0828733A1 (en) 1998-03-18
FI973992A7 (fi) 1997-12-09
CA2217821C (en) 2008-05-06
CN1077888C (zh) 2002-01-16
US5905156A (en) 1999-05-18
DK0828733T3 (da) 2001-12-17
BR9609048A (pt) 1999-02-23
ZA964209B (en) 1997-11-24
MY114924A (en) 2003-02-28
HUP9801751A3 (en) 1999-08-30
KR100437981B1 (ko) 2004-07-16
PT828733E (pt) 2002-02-28
AU6000896A (en) 1996-12-11
FI973992A0 (fi) 1997-10-17
NO975365L (no) 1998-01-15
EP0828733B1 (en) 2001-09-05
RU2160735C2 (ru) 2000-12-20
HU222772B1 (hu) 2003-10-28
AU703276B2 (en) 1999-03-25
PL324042A1 (en) 1998-05-11
WO1996037490A1 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
GT200500007A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia.
ES2096262T3 (es) Nuevas cyclosporins modificadas en la posicion 1.
DK1465626T3 (da) Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
GT199700015A (es) Inhibidores de metaloproteinasa, composiciones farmaceuticas que las contienen y su uso farmaceutico y metodosyeficazproducto intermedio para su preparacion.
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
BR9900320A (pt) Composição antimicrobiana
ES2165441T3 (es) Inhibidores de calpaina y/o catepsina b oxazolidin sustituidos.
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
GT199900131A (es) Derivados del acido hidroxi-pipecolato hidroxamico.
ES2110015T3 (es) Derivados de polisacaridos de heparina, sulfato de heparan, sus fracciones y fragmentos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
ES2163634T3 (es) Benzopiranos y composiciones farmaceuticas que les contienen.
ES2167401T3 (es) Uso de ascorbil-gamma-linolenato o un ascorbil-dihomo-gamma-linolenato para el tratamiento de asma, cancer, enfermedades cardiovasculares y anti-inflamatorias.
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
ES2104133T3 (es) Composiciones cosmeticas o farmaceuticas que contienen glicerofosfolipidos desacilados para uso topico.
ES2190082T3 (es) Concentrados estables de vitamina c.
ECSP003707A (es) Diazepanes
ATE205402T1 (de) Zusammensetzungen welche ein ace-hemmer und ein aldosereductasehemmer enthalten
ES2111175T3 (es) Piperazinas 1,4-disustituidas utiles en el tratamiento del asma y de inflamaciones de las vias respiratorias.
MX9401295A (es) Fosfonatos sustituidos, los procedimientos para supreparacion y composiciones farmaceuticas que los contienen.
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.
AR004484A1 (es) Nuevas 1,2,3,4-tetrahidro-2-naftalenaminas fenilo-sustituidas en el anillo aromatico, su preparacion, sus aplicaciones terapeuticas y las composicionesfarmaceuticas que las contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 828733

Country of ref document: ES